Tosedostat (CHR2797) is a novel, orally bioavailable and potent inhibitor of the M1 family of aminopeptidases with potential antineoplastic activity.

Acebilustat, also known as ZK322, is a novel, oral, potent and selective leukotriene A4 hydrolase inhibitor that is a promising new once-daily oral antiinflammatory drug in development for treatment of cystic fibrosis (CF) and other diseases.

Ubenimex HCl (Bestatin hydrochloride) is a novel and potent CD13 inhibitor or Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor with the potential to be used for cancer treatment.

Bestatin (also called Ubenimex; NK421; NSC 265489) is a potent, naturally occuring and broad-spectrum aminopeptidase-B and leukotriene (LT) A4 hydrolase inhibitor used in the treatment of acute myelocytic leukemia.

LYS 006 is a potent Leukotriene A4 hydrolase (LTA4H) inhibitor for the treatment of Hidradenitis Suppurativa.